BCL3, GBP1, IFI16, and CCR1 as potential brain-derived biomarkers for parietal grey matter lesions in multiple sclerosis
Hua Guo, Zhaocheng Li, Yanqing Wang · 2024
Read BCL3, GBP1, IFI16, and CCR1 as potential brain-derived biomarkers for parietal grey matter lesions in multiple sclerosis by Hua Guo, Zhaocheng Li, Yanqing Wang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11574279.txt.
Description
Hua Guo and co-authors published a research paper in 2024 hunting gene markers that flag the shift of multiple sclerosis into its progressive form. The disease often starts with relapses, then turns steadily worse, and the biology of that turn is murky. The team mined public gene data comparing healthy-looking and damaged tissue from one brain region.
Hundreds of genes differed between the tissues. Network analysis and two learning algorithms converged on four genes tied to immune response as candidate markers. Tests of their predictive strength looked promising for telling progressive disease apart. Immune cell patterns in the tissue added support. The authors offer the four genes as leads for diagnosis research.
Catalog record
| CREATOR | Hua Guo, Zhaocheng Li, Yanqing Wang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |